Ipca Laboratories Ltd.
Snapshot View

925.95 -2.10 ▼-0.2%

16 August 2022, 03:53:48 PM
Volume: 455,476

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ipca.com
Market Cap 23,595.76 Cr.
Enterprise Value(EV) 23,695.60 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 28.40 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 32.75 Trailing Twelve Months Ending 2022-06
Industry PE 32.02 Trailing Twelve Months Ending 2022-06
Book Value / Share 222.32 Trailing Twelve Months Ending 2022-06
Price to Book Value 4.18 Calculated using Price: 930.05
Dividend Yield 0.43 Period Ending 2022-03
No. of Shares Subscribed 25.37 Cr. 253,704,218 Shares
FaceValue 1
Company Profile
Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. Ipca Laboratories is one of the largest suppliers of these APIs worldwide with manufacturing leadership in many APIs globally. It has various APIs and formulations manufacturing facility across the globe. The company has leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy in India

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.23%
1 Week
-8.57%
1 Month
-6.43%
3 Month
-5.87%
6 Month
-5.67%
1 Year
-23.27%
2 Year
-8.01%
5 Year
+344.14%
10 Year
+360.90%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 27.22 12.43 4.31 8.60 9.47 15.28 18.15 27.63 17.87
Return on Capital Employed (%) 27.92 13.78 4.82 9.44 9.94 16.53 19.92 30.92 20.41
Return on Assets (%) 16.19 7.38 2.50 5.17 6.03 10.25 12.47 20.29 13.30

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 1,554 1,960 2,208 2,259 2,455 2,689 3,122 3,627 4,702 5,492
Non Curr. Liab. 510 459 700 663 548 419 313 290 190 602
Curr. Liab. 634 791 904 970 956 1,008 1,098 1,326 1,161 1,466
Minority Int. 16 14 15 77
Equity & Liab. 2,697 3,211 3,812 3,892 3,960 4,116 4,549 5,258 6,066 7,637
Non Curr. Assets 1,300 1,609 2,198 2,270 2,218 2,170 2,171 2,402 2,629 3,180
Curr. Assets 1,397 1,601 1,614 1,622 1,742 1,945 2,378 2,856 3,437 4,457
Misc. Exp. not W/O
Total Assets 2,697 3,211 3,812 3,892 3,960 4,116 4,549 5,258 6,066 7,637

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 3,282 3,144 2,867 3,156 3,258 3,746 4,619 5,395 5,797 5,850
Other Income 52 59 41 55 58 75 87 129 122 68
Total Income 3,334 3,203 2,908 3,211 3,316 3,820 4,706 5,524 5,918 5,917
Total Expenditure -2,570 -2,630 -2,593 -2,741 -2,816 -3,067 -3,729 -3,914 -4,539 -4,688
PBIDT 764 573 314 470 500 753 977 1,610 1,379 1,230
Interest -30 -32 -35 -27 -28 -22 -20 -12 -11 -13
Depreciation -103 -180 -163 -173 -178 -182 -211 -209 -232 -238
Taxation -152 -102 -20 -68 -51 -104 -135 -240 -225 -228
Exceptional Items
PAT 478 259 96 203 244 444 611 1,149 911 750
Minority Interest 3 3 -1 -6 -8
Share Associate 0 -5 -3 -8 -4 -2 -8 -8 -21 -22
Other Related Items
Consolidated Net Profit 479 254 93 195 239 446 606 1,140 884 720
Adjusted EPS 19 10 4 8 9 18 24 45 35 25

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 389 522 468 709 282 341 501 570 1,090 856
Cash Fr. Inv. -260 -369 -689 -218 -149 -135 -165 -510 -521 -855
Cash Fr. Finan. -83 -136 251 -462 -159 -130 -183 -137 -306 427
Net Change 46 17 29 29 -26 75 153 -76 264 428
Cash & Cash Eqvt 57 74 104 169 143 218 371 295 559 991

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 46.07 46.07 46.29 46.29 46.29 46.29 46.29 46.29 46.29
Public 53.93 53.93 53.71 53.71 53.71 53.71 53.71 53.71 53.71
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 12 Aug 2022
Transcript of Analysts/Institutional Investor Meet/Con. Call
IPCA Laboratories Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call
Fri, 12 Aug 2022
Annual General Meeting
IPCA Laboratories Limited has informed the Exchange about Voting results and Scrutinizer report of Annual General Meeting held on 10-Aug-2022
Fri, 12 Aug 2022
Annual General Meeting
IPCA Laboratories Limited has informed the Exchange about Voting results and Scrutinizer report of Annual General Meeting held on 10-Aug-2022

Technical Scans View Details >>

Fri, 12 Aug 2022
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Week Low Close Crossing Last Week Low
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,167.25 914.60 +0.1%
Divi's Laboratories Ltd. 98,918.90 3,732.00 +0.2%
Cipla Ltd. 82,906.37 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. 70,920.35 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. 62,010.73 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. 51,917.53 1,573.70 +2.2%
Piramal Enterprises Ltd. 45,855.65 1,926.70 +0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.35 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 33.43 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-06 33.32 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.69 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.15 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.82 1,573.70 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-06 24.38 1,926.70 +0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.37 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8.44 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-06 3.86 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.50 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.43 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.12 1,573.70 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,926.70 +0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,573.70 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,926.70 +0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,573.70 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,926.70 +0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,573.70 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,926.70 +0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,573.70 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,926.70 +0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,573.70 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,926.70 +0.3%

FAQ's On Ipca Laboratories Ltd.

Can I Buy Ipca Laboratories Shares now?

What is the Share Price of Ipca Laboratories?

What is the Relative Strength Index (RSI) Value of Ipca Laboratories?

What is the Market Capital (MCAP) of Ipca Laboratories?

What are the key metrics to analyse Ipca Laboratories?

What is the Price Performance of Ipca Laboratories?